Northwestern Mutual Wealth Management
IHE icon

Northwestern Mutual Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$174K Sell
2,007
-546
-21% -$47.8K ﹤0.01% 1967
2025
Q4 		$217K Buy
2,553
+567
+29% +$45.3K ﹤0.01% 1835
2025
Q3 		$144K Buy
1,986
+87
+5% +$6K ﹤0.01% 1919
2025
Q2 		$124K Sell
1,899
-343
-15% -$22.3K ﹤0.01% 1928
2025
Q1 		$158K Buy
2,242
+1
+0% +$69 ﹤0.01% 1761
2024
Q4 		$147K Hold
2,241
– – ﹤0.01% 1776
2024
Q3 		$158K Buy
2,241
+1
+0% +$70 ﹤0.01% 1717
2024
Q2 		$149K Buy
2,240
+16
+0.7% +$1.05K ﹤0.01% 1669
2024
Q1 		$151K Sell
2,224
-23
-1% -$1.52K ﹤0.01% 1660
2023
Q4 		$139K Buy
2,247
+42
+2% +$2.47K ﹤0.01% 1651
2023
Q3 		$130K Sell
2,205
-168
-7% -$10.3K ﹤0.01% 1609
2023
Q2 		$142K Buy
2,373
+168
+8% +$9.99K ﹤0.01% 1593
2023
Q1 		$129K Buy
2,205
+3
+0.1% +$181 ﹤0.01% 1598
2022
Q4 		$137K Sell
2,202
-213
-9% -$12.8K ﹤0.01% 1542
2022
Q3 		$136K Sell
2,415
-180
-7% -$11.1K ﹤0.01% 1534
2022
Q2 		$166K Sell
2,595
-162
-6% -$10.3K ﹤0.01% 1450
2022
Q1 		$179K Buy
2,757
+396
+17% +$25.1K ﹤0.01% 1476
2021
Q4 		$157K Buy
2,361
+90
+4% +$5.71K ﹤0.01% 1531
2021
Q3 		$139K Buy
2,271
+900
+66% +$57.2K ﹤0.01% 1488
2021
Q2 		$85K Buy
1,371
+219
+19% +$13.3K ﹤0.01% 1660
2021
Q1 		$68K Sell
1,152
-30
-3% -$1.81K ﹤0.01% 1624
2020
Q4 		$71K Hold
1,182
– – ﹤0.01% 1531
2020
Q3 		$64K Buy
1,182
+9
+0.8% +$485 ﹤0.01% 1421
2020
Q2 		$60K Buy
1,173
+87
+8% +$4.37K ﹤0.01% 1392
2020
Q1 		$49K Buy
1,086
+336
+45% +$16.9K ﹤0.01% 1391
2019
Q4 		$40K Buy
750
+510
+213% +$25.1K ﹤0.01% 1541
2019
Q3 		$11K Hold
240
– – ﹤0.01% 1899
2019
Q2 		$12K Buy
240
+90
+60% +$4.45K ﹤0.01% 1899
2019
Q1 		$8K Hold
150
– – ﹤0.01% 2007
2018
Q4 		$7K Hold
150
– – ﹤0.01% 1940
2018
Q3 		$8K Hold
150
– – ﹤0.01% 1984
2018
Q2 		$8K Hold
150
– – ﹤0.01% 1890
2018
Q1 		$7K Hold
150
– – ﹤0.01% 1833
2017
Q4 		$8K Sell
150
-195
-57% -$10K ﹤0.01% 1814
2017
Q3 		$18K Sell
345
-120
-26% -$6.16K ﹤0.01% 1494
2017
Q2 		$24K Hold
465
– – ﹤0.01% 1325
2017
Q1 		$23K Sell
465
-384
-45% -$19K ﹤0.01% 1279
2016
Q4 		$40K Buy
+849
New +$40.3K ﹤0.01% 1102
2016
Q3 		– Sell
-1,032
Closed -$50K – 810
2016
Q2 		$50K Buy
1,032
+204
+25% +$9.71K ﹤0.01% 904
2016
Q1 		$38K Sell
828
-192
-19% -$8.98K ﹤0.01% 981
2015
Q4 		$55K Hold
1,020
– – ﹤0.01% 764
2015
Q3 		$50K Hold
1,020
– – ﹤0.01% 708
2015
Q2 		$59K Buy
+1,020
New +$59.6K ﹤0.01% 650

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Northwestern Mutual Wealth Management's IHE Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its iShares US Pharmaceuticals ETF (IHE) stake by 21% in Q1 2026, selling an estimated $47.8K and leaving 2,007 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #1967.

Northwestern Mutual Wealth Management first reported a position in IHE in Q2 2015 and has held it in 43 quarters since. The position peaked at $217K in Q4 2025. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Northwestern Mutual Wealth Management held 2,007 shares of iShares US Pharmaceuticals ETF worth $174K as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 546 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $47.8K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #1967 holding.
  • Northwestern Mutual Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and has held it in 43 quarters since.
  • Northwestern Mutual Wealth Management's iShares US Pharmaceuticals ETF position peaked at $217K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.